• Profile
Close

SRPK1 is a poor prognostic indicator and a novel potential therapeutic target for human colorectal cancer

OncoTargets and Therapy Sep 12, 2018

Yi N, et al. - Researchers gauged the expression of serine/arginine protein kinase 1 (SRPK1) in colorectal cancer (CRC) tissues and cells and ascertained its related functions and mechanism. SRPK1 could have predictive value for CRC can be and could be a therapeutic target as well. In CRC tumor tissues and cells, SRPK1 was overexpressed, and was associated with with tumor node metastasis stage. Decreased cell growth and migration, significantly increased apoptosis, and suppressed angiogenesis, were the results of inhibition of SRPK1 by siRNA.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay